Your browser doesn't support javascript.
Integrated genomic surveillance enables tracing of person-to-person SARS-CoV-2 transmission chains during community transmission and reveals extensive onward transmission of travel-imported infections, Germany, June to July 2021.
Houwaart, Torsten; Belhaj, Samir; Tawalbeh, Emran; Nagels, Dirk; Fröhlich, Yara; Finzer, Patrick; Ciruela, Pilar; Sabrià, Aurora; Herrero, Mercè; Andrés, Cristina; Antón, Andrés; Benmoumene, Assia; Asskali, Dounia; Haidar, Hussein; von Dahlen, Janina; Nicolai, Jessica; Stiller, Mygg; Blum, Jacqueline; Lange, Christian; Adelmann, Carla; Schroer, Britta; Osmers, Ute; Grice, Christiane; Kirfel, Phillipp P; Jomaa, Hassan; Strelow, Daniel; Hülse, Lisanna; Pigulla, Moritz; Kreuzer, Pascal; Tyshaieva, Alona; Weber, Jonas; Wienemann, Tobias; Kohns Vasconcelos, Malte; Hoffmann, Katrin; Lübke, Nadine; Hauka, Sandra; Andree, Marcel; Scholz, Claus Jürgen; Jazmati, Nathalie; Göbels, Klaus; Zotz, Rainer; Pfeffer, Klaus; Timm, Jörg; Ehlkes, Lutz; Walker, Andreas; Dilthey, Alexander T.
  • Houwaart T; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Belhaj S; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Tawalbeh E; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Nagels D; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Fröhlich Y; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Finzer P; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Ciruela P; Zotz | Klimas, Düsseldorf, Germany.
  • Sabrià A; Sub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
  • Herrero M; CIBER Epidemiologia y Salud Pública (CIBERESP), Instituto Salud Carlos III, Madrid, Spain.
  • Andrés C; Sub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
  • Antón A; Sub-Directorate General of Surveillance and Response to Public Health Emergencies, Public Health Agency of Catalonia, Barcelona, Spain.
  • Benmoumene A; Microbiology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Asskali D; Microbiology Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Haidar H; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • von Dahlen J; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Nicolai J; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Stiller M; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Blum J; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Lange C; Medizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
  • Adelmann C; Medizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
  • Schroer B; Medizinische Laboratorien Düsseldorf, Düsseldorf, Germany.
  • Osmers U; Solingen Health Authority (Gesundheitsamt Solingen), Solingen, Germany.
  • Grice C; Solingen Health Authority (Gesundheitsamt Solingen), Solingen, Germany.
  • Kirfel PP; MVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
  • Jomaa H; MVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
  • Strelow D; MVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
  • Hülse L; MVZ SYNLAB Leverkusen GmbH, Leverkusen, Germany.
  • Pigulla M; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Kreuzer P; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Tyshaieva A; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Weber J; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Wienemann T; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Kohns Vasconcelos M; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Hoffmann K; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Lübke N; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Hauka S; Zotz | Klimas, Düsseldorf, Germany.
  • Andree M; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Scholz CJ; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Jazmati N; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Göbels K; Labor Dr. Wisplinghoff, Cologne, Germany.
  • Zotz R; Labor Dr. Wisplinghoff, Cologne, Germany.
  • Pfeffer K; Düsseldorf Health Authority (Gesundheitsamt Düsseldorf), Düsseldorf, Germany.
  • Timm J; Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany.
  • Ehlkes L; Zotz | Klimas, Düsseldorf, Germany.
  • Walker A; Institute of Medical Microbiology and Hospital Hygiene, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
  • Dilthey AT; Institute of Virology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Euro Surveill ; 27(43)2022 10.
Article in English | MEDLINE | ID: covidwho-2154580
ABSTRACT
BackgroundTracking person-to-person SARS-CoV-2 transmission in the population is important to understand the epidemiology of community transmission and may contribute to the containment of SARS-CoV-2. Neither contact tracing nor genomic surveillance alone, however, are typically sufficient to achieve this objective.AimWe demonstrate the successful application of the integrated genomic surveillance (IGS) system of the German city of Düsseldorf for tracing SARS-CoV-2 transmission chains in the population as well as detecting and investigating travel-associated SARS-CoV-2 infection clusters.MethodsGenomic surveillance, phylogenetic analysis, and structured case interviews were integrated to elucidate two genetically defined clusters of SARS-CoV-2 isolates detected by IGS in Düsseldorf in July 2021.ResultsCluster 1 (n = 67 Düsseldorf cases) and Cluster 2 (n = 36) were detected in a surveillance dataset of 518 high-quality SARS-CoV-2 genomes from Düsseldorf (53% of total cases, sampled mid-June to July 2021). Cluster 1 could be traced back to a complex pattern of transmission in nightlife venues following a putative importation by a SARS-CoV-2-infected return traveller (IP) in late June; 28 SARS-CoV-2 cases could be epidemiologically directly linked to IP. Supported by viral genome data from Spain, Cluster 2 was shown to represent multiple independent introduction events of a viral strain circulating in Catalonia and other European countries, followed by diffuse community transmission in Düsseldorf.ConclusionIGS enabled high-resolution tracing of SARS-CoV-2 transmission in an internationally connected city during community transmission and provided infection chain-level evidence of the downstream propagation of travel-imported SARS-CoV-2 cases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases, Imported / COVID-19 Type of study: Diagnostic study / Observational study / Qualitative research / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.43.2101089

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Communicable Diseases, Imported / COVID-19 Type of study: Diagnostic study / Observational study / Qualitative research / Randomized controlled trials Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: 1560-7917.ES.2022.27.43.2101089